A comprehensive view of Orthopedics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Grunenthal's injectable Resiniferatoxin gets breakthrough therapy designation from FDA for knee osteoarthritis pain; knee osteoarthritis is a progressive condition affecting over 360 million people worldwide

Abbott receives FDA approval for its spinal cord stimulation systems to treat chronic back pain in people who have limited surgical options; more than 50 million people in the US suffer from chronic pain

Amgen sues Novartis' Sandoz over biosimilar candidate for bone meds Prolia and Xgeva, alleging insufficient manufacturing process details and potential patent infringement

Joint pain injections market projected to reach US$9.20B by 2030, with CAGR growth of 8.6% from 2022-2030; growth driven by rise in osteoarthritis and musculoskeletal illnesses, increased patient awareness of this treatment option

Novartis Pharmaceuticals lists new Phase 2 clinical trial to study safety and efficacy of RHH646 for knee osteoarthritis

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count